Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label …
RD Lopes, RHM Furtado, AVS Macedo, B Bronhara… - The Lancet, 2021 - thelancet.com
… therapeutic anticoagulation with rivaroxaban or enoxaparin … might be associated with lower
in-hospital mortality and less … data with the use of heparins, the current study showed that a …
in-hospital mortality and less … data with the use of heparins, the current study showed that a …
The association of low molecular weight heparin use and in-hospital mortality among patients hospitalized with COVID-19
L Shen, L Qiu, D Liu, L Wang, H Huang, H Ge… - … Drugs and Therapy, 2021 - Springer
… enoxaparin for VTE prophylaxis 40 mg subcutaneously (SC) once daily and or enoxaparin
… practice for clinicians to widely apply anticoagulant therapy in COVID-19 in March 2020. …
… practice for clinicians to widely apply anticoagulant therapy in COVID-19 in March 2020. …
[HTML][HTML] ISTH guidelines for antithrombotic treatment in COVID‐19
S Schulman, M Sholzberg, AC Spyropoulos… - Journal of Thrombosis …, 2022 - Elsevier
… for COVID‐19 demonstrated reduced mortality risk with … low molecular weight heparin or
unfractionated heparin (LMWH/… or mortality with prophylactic heparin over no anticoagulation. …
unfractionated heparin (LMWH/… or mortality with prophylactic heparin over no anticoagulation. …
The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 …
M Guo, Q Han, J Xing, F Xu, J Wang, C Li… - … and Critical Care …, 2022 - journals.lww.com
… mortality of patients with COVID-19 who took anticoagulants … 2019) AND (anticoagulant OR
heparin OR Enoxaparin OR … OR rivaroxaban OR Dabigatran OR apixaban OR edoxaban OR …
heparin OR Enoxaparin OR … OR rivaroxaban OR Dabigatran OR apixaban OR edoxaban OR …
[PDF][PDF] The Effect of Heparinoid as Systemic Prophylactic Anticoagulants on COVID-19 Patient Mortality and Its Safety Profiles: A Systematic Review and Meta-Analysis
AD Anggarany, R Sauriasari, M Alkaff… - Pharmaceutical …, 2021 - scholarhub.ui.ac.id
… use of heparinoid anticoagulants, ie unfractionated heparin and low molecular weight …
with enoxaparin for COVID-19 patients, they specified the prophylactic dosage of LMWH as …
with enoxaparin for COVID-19 patients, they specified the prophylactic dosage of LMWH as …
Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits
… anticoagulants included enoxaparin (1 mg/kg twice daily), apixaban (≥ 5 mg twice daily),
unfractionated heparin … provided mortality benefit to ICU patients with critical COVID-19 disease…
unfractionated heparin … provided mortality benefit to ICU patients with critical COVID-19 disease…
Acetylsalicylic acid compared with enoxaparin for the prevention of thrombosis and mechanical ventilation in COVID-19 patients: A retrospective cohort study
HW Abdelwahab, SW Shaltout… - Clinical Drug …, 2021 - Springer
… with a significant reduction in mortality among patients with COVID-19 [23]. Yuan … heparin
(UFH) and newer direct oral anticoagulants (DOACs) (ie betrixaban, rivaroxaban and apixaban…
(UFH) and newer direct oral anticoagulants (DOACs) (ie betrixaban, rivaroxaban and apixaban…
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
… ), and direct oral anticoagulants (apixaban, rivaroxaban, … between prophylactic anticoagulation
and covid-19 mortality or … with covid-19 and found that initiation of prophylactic, heparin …
and covid-19 mortality or … with covid-19 and found that initiation of prophylactic, heparin …
[HTML][HTML] Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis
NK Wills, N Nair, K Patel, O Sikder, M Adriaanse… - medRxiv, 2022 - ncbi.nlm.nih.gov
… (UFN), or rivaroxaban/apixaban to standard … with thromboprophylaxis - 80% for standard
heparin doses in the most recent … anticoagulation has no effect on short term mortality among …
heparin doses in the most recent … anticoagulation has no effect on short term mortality among …
Effectiveness and Safety of Enoxaparin Versus Unfractionated Heparin as Thromboprophylaxis in Hospitalized COVID-19 Patients: Real-World Evidence
LH AlLehaibi, M Alomar, A Almulhim… - Annals of …, 2023 - journals.sagepub.com
… events or mortality among COVID-19 patients. … anticoagulant for thromboprophylaxis in
COVID-19 patients is scarce, unfractionated heparin (UFH) and low-molecular-weight heparin (…
COVID-19 patients is scarce, unfractionated heparin (UFH) and low-molecular-weight heparin (…